Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | GCC19CART |
Trade Name | |
Synonyms | GCC19-CART|GCC19 CART |
Drug Descriptions |
GCC19CART is a chimeric antigen receptor (CAR) T-cell therapy comprising T-lymphocytes that target guanylate cyclase-C (GUY2C) and CD19, potentially resulting in antitumor activity (Cancer Res (2023) 83 (7_Supplement): 1130). |
DrugClasses | CD19 Immune Cell Therapy 62 |
CAS Registry Number | NA |
NCIT ID | C187317 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
GCC19CART | GCC19CART | 0 | 1 |